Building successful life sciences companies.

With over $200 million of committed capital under management, Genesys is one of the largest Canadian-based exclusively focused on the life sciences industry. View our portfolio.

Building companies, accelerating development.

Genesys Capital is focused on building companies in the high-growth sectors of healthcare and biotechnology. Through its expertise and network, Genesys accelerates the development of commercially viable emerging companies that represent promising life science investment opportunities.

Investor Login

Sign in to our secure investor area to receive personalized updates and information. Login now »

Recent Additions

Tioga Pharmaceuticals, Inc. Raises $10 Million to Advance Phase 3 Clinical Development of Asimadoline in Irritable Bowel
SAN DIEGO, Calif. - April 12, 2012 - Tioga Pharmaceuticals, Inc. today announced the closing of a $10 million Series... Read more
Functional Neuromodulation Secures Additional Funding from Foundation Medical Partners
March 13, 2012, Toronto, Ontario:  Functional Neuromodulation Ltd, a company advancing deep brain stimulation (DBS) therapies for Alzheimer's Disease, announced... Read more